Laparoscopic transperitoneal anterior submesocolic left adrenalectomy

Results after laparoscopic left anterior transperitoneal submesocolic adrenalectomy for the treatment of adrenal benign and malignant disease

Results after laparoscopic left anterior transperitoneal submesocolic adrenalectomy for the treatment of adrenal benign and malignant disease

Minimally invasive adrenalectomy is the treatment of choice for benign adrenal lesions (like Conn’s and Cushing’s syndrome) including pheocromocytoma (PHE) and in selected patients with malignant lesions, also in bilateral lesions. 

Laparoscopic bilateral anterior transperitoneal adrenalectomy. 24 Years experience

Background: The aim of this study is to evaluate the feasibility, safety, advantages and surgical outcomes of laparoscopic bilateral adrenalectomy (LBA) by an anterior transperitoneal approach. Methods: From 1994 to 2018, 552 patients underwent laparoscopic adrenalectomy, unilateral in 531 and bilateral in 21 patients (9 females and 12 males). All patients who underwent LBA were approached via a transperitoneal anterior route and form our study population. Indications included: Cushing’s disease (n = 11), pheochromocytoma (n = 6), Conn’s disease (n = 3) and adrenal cysts (n = 1).

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma